All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

MEDVi vs SkinnyRx: GLP-1 Program Comparison 2026

MEDVi vs SkinnyRx for GLP-1 weight loss in 2026. Compare pricing, medications, provider quality, and which telehealth program delivers more value.

By Dr. Sarah Chen, PharmD|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Sarah Chen, PharmD · Reviewed by Dr. David Kim, MD, FACE

MEDVi vs SkinnyRx: GLP-1 Program Comparison 2026 custom 2026 header image for Provider Comparisons
Custom header image for MEDVi vs SkinnyRx: GLP-1 Program Comparison 2026, Provider Comparisons, and better treatment decision-making.
In This Article

This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides

Search and AI answer brief

Practical answer: MEDVi vs SkinnyRx: GLP-1 Program Comparison 2026

MEDVi vs SkinnyRx for GLP-1 weight loss in 2026. Compare pricing, medications, provider quality, and which telehealth program delivers more value.

Short answer

MEDVi vs SkinnyRx for GLP-1 weight loss in 2026. Compare pricing, medications, provider quality, and which telehealth program delivers more value.

Search intent

This page answers a specific Provider Comparisons question rather than a generic overview.

What to verify

semaglutide, tirzepatide, peptide evidence quality, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

MEDVi vs SkinnyRx for GLP-1 weight loss in 2026. Compare pricing, medications, provider quality, and which telehealth program delivers more value.

Bottom line: SkinnyRx wins on price. MEDVi wins on clinical depth. SkinnyRx is one of the more affordable compounded GLP-1 options available, making it attractive for budget-conscious patients who want straightforward medication access without extras. MEDVi charges more but bundles thorough lab work and physician-led consultations that go deeper than what most discount platforms offer. If cost is your top concern and you're otherwise healthy, SkinnyRx gets the job done. If you want more medical oversight and metabolic tracking, MEDVi justifies the higher price.

Quick Comparison

Feature MEDVi SkinnyRx
Monthly cost$249-$399/mo$149-$299/mo
Consultation feeIncludedIncluded or low separate fee
Medications offeredCompounded semaglutide, tirzepatideCompounded semaglutide, tirzepatide
Provider typeBoard-certified physiciansLicensed providers (MDs, NPs, PAs)
Lab workthorough panel includedNot typically included
App/portalBasic portalBasic portal
Dose titration supportStructured protocolStandard guidance
ShippingFree standardFree or low-cost shipping
Refund policyCase-by-caseLimited
States available30+25+ states

Pricing Breakdown

SkinnyRx positions itself as a value option in the compounded GLP-1 market. Monthly plans start around $149 for lower-dose compounded semaglutide, with tirzepatide options running up to about $299. MEDVi starts at $249 and can reach $399 for higher-tier plans.

Top Telehealth GLP-1 Providers Compared Overall Value Score 0 23 46 69 92 92 78 75 70 FormBlends Hims/Hers Ro Calibrate Based on pricing, support, and patient outcomes
Top Telehealth GLP-1 Providers Compared. Based on pricing, support, and patient outcomes.
View data table
Bar chart showing top telehealth glp-1 providers compared: FormBlends (92), Hims/Hers (78), Ro (75), Calibrate (70)
CategoryOverall Value ScoreDetail
FormBlends92From $299/mo, physician-led
Hims/Hers78Consumer brand, varies
Ro75Telehealth platform
Calibrate70Metabolic health focus
Illustration for MEDVi vs SkinnyRx: GLP-1 Program Comparison 2026

The price gap is real, but it reflects different service levels. MEDVi's pricing includes thorough metabolic bloodwork that would cost $200-$400 if ordered independently through a lab. SkinnyRx typically doesn't include lab work, which means you either skip it (not ideal for health monitoring) or pay for it separately through your own doctor.

For a healthy patient who has a primary care doctor already managing routine labs, SkinnyRx's lower price makes sense. For a patient who needs or wants metabolic panels as part of their weight loss program, MEDVi's bundled approach may actually be the better value despite the higher sticker price.

Medications Available

Both platforms offer compounded semaglutide and tirzepatide. Neither provides brand-name GLP-1 medications. The medications themselves are functionally similar, sourced from licensed compounding pharmacies.

Not sure which GLP-1 is right for you?

Take a 2-minute assessment and get a personalized recommendation after licensed provider review.

Take the Assessment →

The difference is in how dosing and titration are managed. MEDVi follows a more structured titration protocol, with physician-guided dose escalation based on tolerance, side effects, and weight loss progress. SkinnyRx offers standard titration guidance, but the level of hands-on management tends to be lighter.

For patients new to GLP-1 therapy who want more guidance on finding side effects (nausea, appetite changes, injection technique), MEDVi's more involved approach has value. For patients who have taken GLP-1 medications before and know what to expect, SkinnyRx's simplified process is efficient and sufficient.

Patient Experience

Neither platform offers a standout digital experience. Both use functional patient portals that handle the importants: messaging, prescription management, and appointment scheduling. Neither app is on par with larger platforms like Hims or Ro.

MEDVi's onboarding process is more thorough. Expect longer intake questionnaires, more detailed medical history review, and a more in-depth initial consultation. SkinnyRx's onboarding is faster and more simplified, which some patients find refreshing and others find insufficient.

For ongoing check-ins, MEDVi offers scheduled follow-ups with more clinical depth. SkinnyRx follow-ups tend to be brief check-ins focused on refill coordination and basic progress monitoring.

Provider Quality and Support

MEDVi uses board-certified physicians for consultations. SkinnyRx employs a mix of licensed providers including NPs and PAs. Both are qualified to prescribe and manage GLP-1 medications.

The practical difference is in the depth of engagement. MEDVi providers spend more time per consultation and are more likely to discuss lifestyle factors, metabolic biomarkers, and long-term strategy. SkinnyRx providers focus more narrowly on medication management, which keeps things efficient but can feel transactional.

Support responsiveness is comparable, with both platforms operating primarily during business hours via messaging.

Pros and Cons

MEDVi

Pros:

  • Physician-led consultations with clinical depth
  • thorough lab work included
  • Structured dose titration protocols
  • More personalized care approach

Cons:

  • Significantly higher monthly cost
  • Basic digital platform
  • May include services some patients don't need
  • Slower onboarding due to thorough intake

SkinnyRx

Pros:

  • Lower monthly pricing
  • Fast, simplified onboarding
  • Straightforward medication access
  • Good option for experienced GLP-1 patients

Cons:

  • Lab work not included
  • Less clinical depth in consultations
  • Provider interactions can feel brief
  • Smaller state coverage
  • Limited refund options

Who Should Choose MEDVi

MEDVi is the right choice for patients who are new to GLP-1 therapy, have comorbidities that need monitoring, or want thorough metabolic tracking integrated into their weight loss program. The higher cost pays for clinical infrastructure that budget platforms don't provide.

Who Should Choose SkinnyRx

SkinnyRx makes sense for healthy patients who want affordable access to compounded GLP-1 medication without paying for services they don't need. If you have experience with these medications, have a separate doctor managing your health, and want to minimize monthly costs, SkinnyRx delivers what it promises at a fair price.

How FormBlends Compares

FormBlends offers the physician-supervised clinical depth of MEDVi with a broader treatment toolkit. Beyond GLP-1 weight loss medication, FormBlends provides peptide wellness therapy for recovery, energy, and metabolic support. Every patient works with a licensed physician, and the platform is designed for patients who want more than just a prescription. For those who want a single provider managing both weight loss and broader wellness improvement, FormBlends.com offers an approach worth considering.

Frequently Asked Questions

Is SkinnyRx safe?

SkinnyRx works with licensed providers and licensed compounding pharmacies. The medications are legally prescribed and dispensed. But the lighter clinical oversight compared to platforms like MEDVi means you should ideally have a primary care doctor monitoring your overall health while using a service like SkinnyRx.

Does MEDVi's lab work replace my regular doctor visits?

No. MEDVi's metabolic panels are focused on weight loss and metabolic health markers. They don't replace thorough annual physicals or screenings your primary care doctor would order. Think of them as an addition, not a replacement.

Can I switch from SkinnyRx to MEDVi mid-treatment?

Yes. You can switch platforms at any time. You'll need to complete MEDVi's intake process, but your existing GLP-1 treatment history will inform their prescribing decisions. There's no need to restart from scratch medically.

Do either platform offer weight loss beyond GLP-1 medications?

MEDVi focuses on metabolic health improvement alongside GLP-1 therapy, including nutritional guidance. SkinnyRx is primarily a medication access platform. Neither offers the breadth of wellness services available through platforms like FormBlends.

Want physician-supervised GLP-1 therapy plus peptide wellness options? See what FormBlends offers and decide if it matches your goals.

Research Snapshot

Head-to-head comparison
Page type
Head-to-head comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Calibrate official source
Official source
Hers official source
Official source
Hims official source
Official source
MEDVi official source
Official source
Ro Body official source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For MEDVi vs SkinnyRx: GLP-1 Program Comparison 2026, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Randomized trialGLP-1 liver and NASH evidence2023

Semaglutide 2.4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis

Supports careful discussion of semaglutide in NASH-related cirrhosis without overstating outcomes.

PubMed

Randomized trialGLP-1 liver and NASH evidence2022

Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis

Used for liver-disease pages where semaglutide appears in exploratory NASH combination research.

PubMed

Randomized trialGLP-1 liver and NASH evidence2024

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease

Useful when liver-fat claims involve next-generation incretin or pipeline agents.

PubMed

ReviewGHK-Cu and copper peptide evidence2015

The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging

Anchor review for copper peptide gene-expression and tissue-repair claims.

PubMed

ReviewGHK-Cu and copper peptide evidenceSearch

Effects of glycyl-histidyl-lysine-Cu on wound healing

Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.

PubMed

ReviewGHK-Cu and copper peptide evidenceSearch

Copper peptide and skin remodeling literature

Used to keep skin and collagen claims connected to PubMed rather than cosmetic marketing alone.

PubMed

Comparison decision path

Use this comparison to narrow the provider review question

Direct answer

MEDVi vs SkinnyRx: GLP-1 Program Comparison 2026 should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

After comparing, use the get-started flow to route your goals and health history into the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

MEDVi vs SkinnyRx for GLP-1 weight loss in 2026. Compare pricing, medications, provider quality, and which telehealth program delivers more value. "MEDVi vs SkinnyRx: GLP-1 Program Comparison 2026" earns its keep when it helps a reader move from a broad question to a cleaner next step. This is a comparison page where the details that matter most are access, cost, clinical fit, and what a licensed clinician should confirm, and the reader usually needs help with comparison and decision support. Pay extra attention to cost and coverage, provider access and related tags such as comparison, medication comparison, head-to-head. Because this article has 10 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Verify total monthly cost, refill timing, dose escalation pricing, and what is included before paying.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for MEDVi vs SkinnyRx

This update makes MEDVi vs SkinnyRx more specific by tying semaglutide, tirzepatide, cash-pay pricing, safety signals, medvi, skinnyrx to the page's original clinical, cost, access, or comparison angle.

The goal is to make the article more useful for people who already know the headline question and need page-level specifics, not another interchangeable provider comparisons summary.

For 2026 review, the content emphasizes current verification, treatment fit, and patient-safety questions that can be discussed with a qualified provider.

MEDVi vs SkinnyRx custom 2026 image for provider comparisons on FormBlends

Custom 2026 image for MEDVi vs SkinnyRx, provider comparisons, and better treatment decision-making.

Image description: Unique image for this page covering MEDVi vs SkinnyRx, provider comparisons, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Disclosure: FormBlends is one of the providers discussed in this article. Our editorial team independently researches and verifies all pricing and claims. Pricing was last verified in March 2026. Read our editorial policy.

Written by Dr. Sarah Chen, PharmD

Clinical Pharmacist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.